Current Rheumatology Reports

, Volume 12, Issue 4, pp 295–299 | Cite as

Development of Screening Tools to Identify Psoriatic Arthritis

  • Patrick Dominguez
  • Dafna D. Gladman
  • Philip Helliwell
  • Philip J. Mease
  • M. Elaine Husni
  • Abrar A. Qureshi
Article

Abstract

Psoriatic arthritis (PsA) is an inflammatory arthritis associated with psoriasis that follows an indolent and progressive course. A delay in diagnosis and treatment may lead to irreversible changes such as erosive arthritis, which lead to permanent physical disability and deformity. Administration of a well-designed screening tool can increase detection of PsA and help determine the prevalence of PsA in a given population. Several tools have been developed to help clinicians screen for PsA. Members of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis recently led an effort to develop and validate three PsA screening tools: the Psoriatic Arthritis Screening and Evaluation tool, the Psoriasis Epidemiology Screening Tool, and the Toronto Psoriatic Arthritis Screen.

Keywords

Psoriatic arthritis Psoriasis Screening 

References

Papers of particular interest, published recently, have been highlighted as: • Of importance, •• Of major importance

  1. 1.
    Zachariae H: Prevalence of joint disease in patients with psoriasis: implications for therapy. Am J Clin Dermatol 2003, 4:441–447.CrossRefPubMedGoogle Scholar
  2. 2.
    Mease P, Goffe BS: Diagnosis and treatment of psoriatic arthritis. J Am Acad Dermatol 2005, 52:1–19.CrossRefPubMedGoogle Scholar
  3. 3.
    Brockbank J, Gladman D: Diagnosis and management of psoriatic arthritis. Drugs 2002, 62:2447–2457.CrossRefPubMedGoogle Scholar
  4. 4.
    Gladman DD, Brockbank J: Psoriatic arthritis. Expert Opin Investig Drugs 2000, 9:1511–1522.CrossRefPubMedGoogle Scholar
  5. 5.
    Taylor W, Gladman D, Helliwell P, et al.: Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 2006, 54:2665–2673.CrossRefPubMedGoogle Scholar
  6. 6.
    Peloso PM, Hull P, Reeder B: The psoriasis and arthritis questionnaire (PAQ) in detection of arthritis among patients with psoriasis. Arthritis Rheum 1997, 40:S64.Google Scholar
  7. 7.
    Alenius GM, Stenberg B, Stenlund H, et al.: Inflammatory joint manifestations are prevalent in psoriasis: prevalence study of joint and axial involvement in psoriatic patients, and evaluation of a psoriatic and arthritic questionnaire. J Rheumatol 2002, 29:2577–2582.PubMedGoogle Scholar
  8. 8.
    • Qureshi AA, Dominguez P, Duffin KC, et al.: Psoriatic arthritis screening tools. J Rheumatol 2008, 35:1423–1425. This is an update on the development of screening tools for PsA that was presented during the 2009 GRAPPA annual meeting. It includes feedback from GRAPPA members on what should constitute an effective screening tool.Google Scholar
  9. 9.
    • Husni ME, Meyer KH, Cohen DS, et al.: The PASE questionnaire: pilot-testing a psoriatic arthritis screening and evaluation tool. J Am Acad Dermatol 2007, 57:581–587. This was the first validation pilot study of the PASE questionnaire, jointly developed by rheumatologists and dermatologists, which shows the PASE to be an effective screening tool to identify inflammatory arthritis and to distinguish it from noninflammatory arthritis.Google Scholar
  10. 10.
    •• Dominguez PL, Husni ME, Holt EW, et al.: Validity, reliability, and sensitivity-to-change properties of the psoriatic arthritis screening and evaluation questionnaire. Arch Dermatol Res 2009, 301:573–579. This was the second validation study of the PASE questionnaire in a larger patient population that showed the PASE to be sensitive to change and to have test–retest reliability.Google Scholar
  11. 11.
    Gladman DD, Schentag CT, Tom B, et al.: Development and validation of a screening questionnaire for psoriatic arthritis. Arthritis Rheum 2007, 56(Suppl 9):S798.Google Scholar
  12. 12.
    •• Gladman DD, Schentag CT, Tom BD, et al.: Development and initial validation of a screening questionnaire for psoriatic arthritis: the Toronto Psoriatic Arthritis Screen (ToPAS). Ann Rheum Dis 2009, 68:497–501. This article describes the initial development of the ToPAS questionnaire, a psoriasis and PsA screening tool, and its validation in various clinical settings.Google Scholar
  13. 13.
    •• Ibrahim GH, Buch MH, Lawson C, et al.: Evaluation of an existing screening tool for psoriatic arthritis in people with psoriasis and the development of a new instrument: the Psoriasis Epidemiology Screening Tool (PEST) questionnaire. Clin Exp Rheumatol 2009, 27:469–474. This article describes the development and validation of the PEST questionnaire, a PsA screening tool, in a community-based setting.Google Scholar
  14. 14.
    Gelfand JM, Gladman DD, Mease PJ, et al.: Epidemiology of psoriatic arthritis in the population of the United States. J Am Acad Dermatol 2005, 53:573.CrossRefPubMedGoogle Scholar
  15. 15.
    Feldman SR, Fleischer AB Jr, Cooper JZ: New topical treatments change the pattern of treatment of psoriasis: dermatologists remain the primary providers of this care. Int J Dermatol 2000, 39:41–44.CrossRefPubMedGoogle Scholar
  16. 16.
    Alenius GM, Stenberg B, Stenlund H, et al.: Inflammatory joint manifestations are prevalent in psoriasis: prevalence study of joint and axial involvement in psoriatic patients, and evaluation of a psoriatic and arthritic questionnaire. J Rheumatol 2002, 29:2577–2582.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  • Patrick Dominguez
    • 1
  • Dafna D. Gladman
    • 2
  • Philip Helliwell
    • 3
  • Philip J. Mease
    • 4
  • M. Elaine Husni
    • 5
  • Abrar A. Qureshi
    • 6
  1. 1.Department of Dermatology, Brigham and Women’s HospitalHarvard Medical SchoolBostonUSA
  2. 2.Toronto Western Research InstituteUniversity of TorontoTorontoCanada
  3. 3.Academic Unit of Musculoskeletal and Rehabilitation MedicineUniversity of LeedsLeedsUK
  4. 4.Division of Rheumatology Research, Swedish Medical CenterUniversity of Washington School of MedicineSeattleUSA
  5. 5.Rheumatic and Immunologic Diseases, Orthopedic and Rheumatologic InstituteCleveland Clinic FoundationClevelandUSA
  6. 6.Department of Dermatology, Brigham and Women’s HospitalHarvard Medical SchoolBostonUSA

Personalised recommendations